Evidence map›Paper›PMID 29649232›Full record

ArticlePloS one2018

The experience of discrimination of individuals living with chronic hepatitis B in four provinces of China.

Bingfeng Han, Qianli Yuan, Yuhui Shi, Lai Wei, Jinlin Hou, Jia Shang, Ying Han, Cunduo Jin, Po-Lin Chan, Hui Zhuang and 2 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 1 pooled it
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 1 synthesis or guideline pooled it, 42 citations in OpenAlex.

  1. Guideline
  2. Article
  3. Traveling with chronic viral hepatitis.Tropical diseases, travel medicine and vaccines · 2026
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Social challenges experienced by Hepatitis B patients: A mixed method study.Journal of family medicine and primary care · 2023
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 7 institutions in 1 country.

Bingfeng HanDepartment of Laboratorial Science and Technology, School of Public Health, Peking University, Beijing, China.
Qianli YuanNational Immunization Program, Chinese Center for Disease Control and Prevention, Beijing, China.
Yuhui ShiDepartment of Laboratorial Science and Technology, School of Public Health, Peking University, Beijing, China.
Lai WeiHepatology Unit, Peking University People's Hospital, Beijing, China.
Jinlin HouHepatology Unit, Nanfang Hospital, Guangzhou, China.
Jia ShangHepatology Unit, Henan Provincial People's Hospital, Zhengzhou, China.
Ying HanHepatology Unit, Xijing Hospital, The Fourth Military Medical University, Xi'an, China.
Cunduo JinCentral sterile supply Department, 302 Military Hospital of China, Beijing, China.
Po-Lin ChanWorld Health Organization China, Beijing, China.
Hui ZhuangDepartment of Microbiology and Center of Infectious Diseases, School of Basic Medical Sciences, Peking University Health Science Center, Beijing, China.
Jie LiDepartment of Microbiology and Center of Infectious Diseases, School of Basic Medical Sciences, Peking University Health Science Center, Beijing, China.
Fuqiang CuiDepartment of Laboratorial Science and Technology, School of Public Health, Peking University, Beijing, China.
Peking University · CN302 Military Hospital of China · CNAir Force Medical University · CNChinese Center For Disease Control and Prevention · CNHenan Provincial People's Hospital · CNNanfang Hospital · CNPeking University People's Hospital · CN

Funding

World Health Organization 001
6 · The paper itself

Abstract

objectivesTo assess chronic hepatitis B (CHB) patients' knowledge about hepatitis B and their experience of discrimination with regard to study, work, and daily life.

methodsWe administered a questionnaire to 797 CHB patients in four provinces of China and used one-way analysis of variance (ANOVA) and a generalized linear model (GLM) to identify factors associated with discrimination.

resultsCHB patients had low levels of knowledge about hepatitis B. Patients under 40 years of age with a junior college education or above knew more about hepatitis B than CHB patients over 40 years of age who had only a high school education. Three-fourths of patients had experienced discrimination because of their hepatitis B infection, with no differences in the proportion experiencing discrimination by sex or age. People with more education reported less discrimination. Patients in Beijing and Henan province perceived less discrimination than those in Shaanxi and Guangdong provinces. Discrimination was significantly associated with negative emotions. CHB patients had little awareness of China's anti-discrimination laws and policies. Among patients who had experienced discrimination, fewer than 10% knew organizations or institutions that could offer help. Over 60% of CHB patients who experienced discrimination chose not to respond.

conclusionCHB patients in China commonly experienced discrimination, which was associated with significant, negative emotional stress. To mitigate the damaging effects of discrimination, our study suggests raising general population knowledge about hepatitis B, raising awareness of the availability of legal protection and organizations that can fight discrimination, and providing psychological support for CHB patients.

Indexed as

Social DiscriminationSurveys and QuestionnairesAdultChinaCivil RightsFemaleHealth Knowledge, Attitudes, PracticeHepatitis B, ChronicHumansMaleMiddle AgedQuality of Life

Identifiers

PMID29649232
PMCPMC5896961
OpenAlexW2796590669

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.